T. Rowe Price Associates »

Aquestive Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $119k 24k 4.99
2024-06-30 $0 24k 0.00

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
VR Adviser
BlackRock
Vanguard Group
Franklin Resources
Geode Capital Management
Blue Owl Capital Holdings
Citadel Advisors
State Street Corporation
Janney Montgomery Scott
Woodline Partners
Invesco
Nuveen Asset Management
Susquehanna International

View all funds holding Aquestive Therapeutics